Menu Back to 6th-DIA-CMC-Forum-in-Japan


Registration has been closed for this forum.

This forum will be conducted in Japanese Language only.

Click Here to View the Program in Japanese.

Who should attend?

The program will benefit those with the following interests:

  • Regulatory Affairs
  • CMC Regulatory Affairs
  • Drug Substance Development and Manufacturing
  • Formulation Development and Manufacturing
  • Quality Assurance
  • CMC Life Cycle Management
  • CMC Project Management

Program Committee

  • Noriko  Katori, PhD
    Noriko Katori, PhD Division of Drugs
    National Institute of Health Sciences, Japan
  • Takeshi  Hamaura, PhD
    Takeshi Hamaura, PhD Vice President, CMC Planning Department, Pharmaceutical Technology Division
    Daiichi Sankyo Co., Ltd., Japan
  • Yukio  Hiyama, PhD
    Yukio Hiyama, PhD Visiting Researcher
    National Institute of Health Sciences, Japan
  • Fusashi  Ishikawa, PhD, MSc
    Fusashi Ishikawa, PhD, MSc Director, Formulation Property Research Group, Formulation R&D Laboratories
    Sumitomo Dainippon Pharma Co., Ltd., Japan
  • Yoshihiro  Matsuda, PhD
    Yoshihiro Matsuda, PhD Senior Scientist (for Quality), Pharmacist
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Sachi  Nakane
    Sachi Nakane CMC Documentation 1
    Bayer Yakuhin, Ltd., Japan
  • Tomoaki  Sakamoto, PhD
    Tomoaki Sakamoto, PhD Section Chief
    National Institute of Health Sciences, Japan
  • Satomi  Yagi
    Satomi Yagi Reviewer, Office of New Drug IV
    Pharmaceuticals and Medical Devices Agency (PMDA), Japan
  • Mio  Yamazaki
    Mio Yamazaki CMC RA Dept., Regulatory Affairs, Global Medical
    GlaxoSmithKline K.K., Japan
Load More

Contact us

Please contact the DIA Japan office in Tokyo for further information.

Tel: +81-3-6214-0574
Fax: +81-3-3278-1313

Digital Learning Catalog

DIA Learning: 2018 eLearning Soultions